Matthew B. Klein, Director at ClearPoint Neuro, Inc. (CLPT), sold 16,000 shares at $11.59 ($185K) on 2026-05-21, disclosed to the SEC on 2026-05-26.
Open-market sale of $185k CLPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |
| PTCT | SELL | 2026-02-20 | $511K | — | Filing → |